Johnson & Johnson to start testing on new type of HIV vaccine in U.S. and Europe

A vaccine targeting multiple strains of HIV is going into late-stage testing phase in the United States and Europe later this year.

Pharmaceutical giant Johnson & Johnson is getting ready to test a new type of vaccine against HIV, the virus that causes AIDS, hoping to end the epidemic that has...